Guidelines for the diagnosis and treatment of adrenal insufficiency in the adult.

Adrenal insufficiency (AI) is a disease characterized by a deficient production or action of glucocorticoids, with or without deficiency in mineral corticoids and/or adrenal androgens. It can result from disease intrinsic to the adrenal cortex (primary AI), from pituitary diseases that hamper the release of corticotropin (secondary AI) or from hypothalamic disorders that impair the secretion of the corticotropin-releasing hormone (tertiary AI). It is a disease with a low prevalence but its impact on the affected individual is very high as it can be life-threathening if not treated or lead to health problems if inadequately treated. However, currently there are no specific guidelines for the management of this disease. Therefore, at the proposal of the Spanish Society of Endocrinology and Nutrition (SEEN) board, a task-force under the Neuroendocrinology Knowledge Area of the SEEN was established, with the mandate of updating the diagnosis and treatment of AI. In fulfilment of this mandate the task-force has elaborated the present guide that, based on a comprehensive review of literature, is intended to provide an answer to questions related to the management of this disease. It is, therefore, an essentially practical document, mainly aimed at guiding the health professionals involved in the care of IA patients.

[Prevalence of iodine deficiency in pregnant women in the health area of Palencia (Spain)]. / Yododeficiencia en mujeres gestantes del Area Sanitaria de Palencia (España).

BACKGROUND: Iodine deficiency in pregnant women may result in substantial and irreversible impairment in fetal brain development, even from the first few weeks of pregnancy. OBJECTIVE: To assess the nutritional iodine status of pregnant women in our health area and its relationship with dietary factors and thyroid function and to suggest treatment guidelines. PATIENTS AND METHOD: A study in 164 pregnant women in early pregnancy was carried out. Data on urinary iodine concentrations were gathered from 24-hour urine samples. Data on anthropometric parameters and thyroid function were included. Information on dietary habits in the previous week was collected using a nutritional questionnaire. All data were obtained before iodine supplements were administered. RESULTS: The median urinary iodine concentration was 92 [p25-p75 range, 71-139] microg/l. Seventy-eight percent of urinary iodine values were under 150 microg/l. Women who took iodized salt had higher levels of urinary iodine concentrations than women without iodized salt intake. CONCLUSIONS: Seventy-eight percent of pregnant women in our health area were iodine deficient. Iodized salt intake is related to iodine sufficiency and to increased urinary iodine concentrations. Measures to increase intake of iodized salt among the population should be implemented. Iodized salt supplements should be systematically prescribed in women from the beginning of pregnancy.